TYMS
TYMS (thymidylate synthetase, also known as thymidylate synthase, TS, Tsase, TMS and HsT422) is the enzyme that converts dUMP to dTMP in de novo thymidylate biosynthesis. It supplies the dTMP needed for DNA replication and repair. Browse Assay Genie's current range of TYMS research reagents below, or read on for the biology behind the target.
TYMS catalyses the reductive methylation of 2'-deoxyuridine 5'-monophosphate (dUMP) to thymidine 5'-monophosphate (dTMP). The reaction uses 5,10-methylenetetrahydrofolate as both the one-carbon donor and the reductant. In this way the enzyme contributes to the mitochondrial and nuclear de novo thymidylate biosynthesis pathway and maintains the dTMP pool that is critical for DNA replication and repair.
The TYMS protein belongs to the thymidylate synthase family. HGNC places it among the small molecule methyltransferases, in the group of methyltransferases with unique structures. UniProt records its localisation in the nucleus and cytoplasm, and in the mitochondrion, including the matrix and inner membrane. The mouse and rat orthologues are both named Tyms, so the TYMS gene is readily studied in common model systems.
TYMS has long been of interest as a target for cancer chemotherapeutic agents. It is considered the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine and some folate analogues. Polymorphisms in the gene may be associated with the aetiology of neoplasia, including breast cancer, and with response to chemotherapy. NCBI Gene also notes that expression of this gene and of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1, vary inversely as cell growth progresses from late-log to plateau phase.
TYMS drives de novo dTMP synthesis from dUMP, making it a central enzyme for studying thymidylate supply to DNA synthesis.
The dTMP pool maintained by TYMS is critical for DNA replication and repair, so the enzyme is relevant to genome maintenance studies.
TYMS is the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine and some folate analogues, and is a long-standing chemotherapeutic target.
Polymorphisms in the TYMS gene may be associated with neoplasia, including breast cancer, and with response to chemotherapy.
TYMS catalyses the methylation of dUMP to dTMP, using 5,10-methylenetetrahydrofolate as one-carbon donor and reductant. This supports mitochondrial and nuclear de novo thymidylate biosynthesis and maintains the dTMP pool needed for DNA replication and repair.
The HGNC full name is thymidylate synthetase, and UniProt calls the protein thymidylate synthase. Aliases include TS, Tsase, TMS and HsT422. The enzyme has the EC number 2.1.1.45 and belongs to the thymidylate synthase family.
Mouse and rat both have a Tyms orthologue; check the datasheet of any product for its validated reactivity. TYMS is a chemotherapy target for 5-fluorouracil, and polymorphisms may be associated with neoplasia, including breast cancer, and drug response.
Other nucleotide-metabolism enzymes, folate-pathway proteins and DNA synthesis markers studied alongside TYMS.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P04818; product specifications from Assay Genie datasheets.